Herbalife Nutrition Ltd (HLF)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Herbalife Nutrition Ltd.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 12.40 $ — 38% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/03/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
4 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -1.1% failed
- More than 10% revenue growth is expected for the coming year 2.6% failed
- Share count grows by less than 3% a year 1.4% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") 5.9% failed
- Gross margin at 40% or higher and without meaningful erosion 75.6% passed
- Goodwill from acquisitions does not grow faster than revenue 3.6% failed
- Net debt below twice EBITDA 3.3 x EBITDA failed
- Operating cash flow covers the profits of the last three years 351 m passed
- Return on capital at 15% or higher, or up versus two years ago 24.9% passed
- Insiders hold at least 10% or are net buyers 5.1% failed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 47.8% above the current price.
- Consensus
- Sell
- Analyst Ratings
- 5
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2.56 | 2.48 – 2.64 | 5,239 | 20.7% | 2 |
| 12/31/2027 | 3.15 | 3.08 – 3.23 | 5,374 | 23.2% | 2 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.63 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 1.74 | 1,615.00 | 1,207 | -0.60 | 14.70 | 70 | 44 |
| 2025: Q1 | 0.49 | 104.40 | 1,222 | -3.40 | 4.10 | 0 | -18 |
| 2025: Q2 | 0.48 | 932.70 | 1,259 | -1.70 | 3.90 | 96 | 73 |
| 2025: Q3 | 0.42 | -10.70 | 1,274 | 2.70 | 3.40 | 139 | 118 |
| 2025: Q4 | 0.82 | -52.70 | 1,283 | 6.30 | 6.70 | 98 | 80 |
| 2026: Q1 | 0.57 | 15.80 | 1,317 | 7.80 | 4.70 | 114 | 103 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 4,488 | 458 | 260 | 1.51 | 367 | 196 | 2,565 |
| 2017 | 4,428 | 617 | 214 | 1.29 | 591 | -335 | 2,895 |
| 2018 | 4,892 | 683 | 297 | 1.98 | 648 | -723 | 2,790 |
| 2019 | 4,877 | 568 | 311 | 2.20 | 458 | -390 | 2,679 |
| 2020 | 5,542 | 641 | 373 | 2.77 | 629 | -856 | 3,076 |
| 2021 | 5,803 | 734 | 447 | 4.13 | 460 | -1,392 | 2,820 |
| 2022 | 5,204 | 545 | 321 | 3.23 | 353 | -1,266 | 2,732 |
| 2023 | 5,062 | 356 | 142 | 1.42 | 358 | -1,060 | 2,809 |
| 2024 | 4,993 | 386 | 254 | 2.50 | 285 | -801 | 2,728 |
| 2025 | 5,038 | 442 | 228 | 2.20 | 333 | -515 | 2,786 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
Herbalife Ltd. bietet zusammen mit seinen Tochtergesellschaften Gesundheits- und Wellnessprodukte in Nordamerika, Mexiko, Süd- und Mittelamerika, Europa, im Nahen Osten, in Afrika, China und im asiatisch-pazifischen Raum an.
| Employees | 8,500 |
|---|---|
| Headquarters | Los Angeles, CA |
| Address | P.O. Box 80210, 90080-0210 Los Angeles, United States |
| Phone | 310 410 9600 |
| Website | herbalife.com |
| IPO Date | 16. Dec 2004 |
| ISIN | USG4412G1016 |
| Stock Split | 2:1 on 05/15/2018 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Michael O. Johnson | Executive Chairman | 1955 |
| Stephan Paulo Gratziani | Chief Executive Officer | 1969 |
| Robert C. Levy | President | 1959 |
| John G. DeSimone | Chief Financial Officer | 1967 |
| Henry C. Wang | Chief Legal Officer & Corporate Secretary | 1970 |
| Frank Lamberti | Chief Commercial Officer | 1973 |
| Susan B. Peterson | Founder | – |
| Troy Hicks | Chief Operating Officer | 1978 |
| Jehangir D. Irani | Senior VP & Chief Accounting Officer | – |
| Erin Banyas | Head of Investor Relations | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Chart
Interactive price chart (TradingView).
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.